Akero Therapeutics
See how your profile stacks up against this role.
We compared the job requirements to your profile to show where you're strong and where you fall short.
COMPANY BACKGROUND
Akero Therapeutics, a Novo Nordisk company, is a clinical stage biopharmaceutical company focused on discovering and developing transformational treatments for patients with serious metabolic diseases marked by high unmet need. Our current focus is on advancing our lead program efruxifermin (EFX) to provide a powerful new treatment for patients with MASH(metabolic dysfunction-associated steatohepatitis).
We are a team of problem solvers dedicated to pursuing bold scientific approaches to build a brighter future for patients. Our diverse skill sets and backgrounds, desire to learn from each other and collaborative spirit breed a culture where everyone feels inspired to bring their best thinking to work, and to bring out the best in others.
Akero Therapeutics is developing medicines that deliver transformational outcomes to patients with serious metabolic diseases. Our lead clinical program, Efruxifermin (EFX), is a treatment for non-alcoholic steatohepatitis (NASH), rapidly emerging as the leading cause of liver disease around the world. Efruxifermin is a novel long-acting fibroblast growth factor 21 (FGF21) agonist, with the potential to substantially improve the lives of patients with NASH, and other serious metabolic diseases.
We are a team of problem solvers dedicated to pursuing bold scientific approaches to build a brighter future for patients. Our diverse skill sets and backgrounds, desire to learn from each other and collaborative spirit breed a culture where everyone feels inspired to bring their best thinking to work, and to bring out the best in others.
The Clinical TMF Operations Administrator will contribute to the execution of the Phase 3 clinical development program for EFX. Key responsibilities include, but are not limited to clinical protocol development, medical monitoring, data analysis and reporting of results for regulatory submissions or scientific presentations and publications.
Relationships:
Reports to the Sr Dir, Clinical Program Management and also takes direction from the Sr Clinical Program Manager.
The position will interact with all areas of Clinical within Akero Therapeutics and Novo Nordisk. The position interacts with team members at the IC through Vice President level. The position requires experience interacting with senior level positions in each of these departments and a good understanding of how these peer teams operate, ideally through experience working within these teams (broad experience).
Externally, the position will engage with CROs and potentially with regulatory authorities. For CROs it will be entry level through Sr Management level. For regulatory, the person needs to have the ability and experience to engage directly with auditors (FDA/GLOBAL). Once again emphasizing the need for significant experience.
Job Responsibilities
Clinical TMF Operations Management
eTMF Health & Oversight
Quality, Compliance & Inspection Readiness
Operational Execution & Support
Strategy, Process Improvement & Leadership
Qualifications
The base compensation range for this position is $99,600 to $155,400. Base compensation is determined based on a number of factors. This position is also eligible for a company bonus based on individual and company performance.
Akero Therapeutics, a Novo Nordisk company, offers long-term incentive compensation depending on the position's level or other company factors.
Employees are also eligible to participate in Company employee benefit programs including medical, dental and vision coverage; life insurance; disability insurance; 401(k) savings plan; flexible spending accounts; employee assistance program; tuition reimbursement program; and voluntary benefits such as group legal, critical illness, identity theft protection, pet insurance and auto/home insurance. The Company also offers time off pursuant to its sick time policy, flex-able vacation policy, and parental leave policy.
The job posting is anticipated to close on July 21, 2026. The Company may however extend this time-period, in which case the posting will remain available on our careers website at https://akerotx.com/job-opportunities.
EEO Statement:
Novo Nordisk is an equal opportunity employer. Qualified applicants will receive consideration for employment without regard to race, ethnicity, color, religion, sex, gender identity, sexual orientation, national origin, disability, protected veteran status or any other characteristic protected by local, state or federal laws, rules or regulations.
After you apply, unlock the direct contact details of the people who actually make the call. A quick follow-up makes you 5x more likely to land an interview.
Marcus Rivera
Chief Revenue Officer

Hunt St

BP

Arch Global Services (Philippines) Inc.

Tether.io

talentpluto

Akero Therapeutics